SCHEMBL875152

SCHEMBL875152

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3NCc3ccco3)cc2)cc1)[C@@H]1CCCN1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 1/20 0.41
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
GAA P10253 1/20 0.36
REN P00797 1/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845043 0.92 ALDH1A1 (0.47) ALDH1A1HSD17B10NPSR1GAAREN
SCHEMBL874311 0.88 ALDH1A1 (0.47) ALDH1A1HSD17B10HDAC3HDAC4HDAC1
SCHEMBL10119480 0.85 GAA (0.39) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL874324 0.84 MAPK1 (0.42) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL874056 0.81 TRPV1 (0.42) ALDH1A1NPSR1CYP2C9CYP2C19MEN1
SCHEMBL845682 0.80 ALDH1A1 (0.54) ALDH1A1HSD17B10GAACYP2C9CYP2C19
SCHEMBL10119639 0.79 MEN1 (0.46) ALDH1A1NPSR1GAACYP2C9CYP2C19
SCHEMBL10119315 0.79 MAPT (0.40) ALDH1A1CYP2C9CYP2C19MEN1MAPT
SCHEMBL872532 0.79 TRPV1 (0.44) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL10119344 0.79 CYP2C9 (0.39) ALDH1A1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed